Allurion to Participate in the Jefferies London Healthcare Conference

Rhea-AI Summary

Allurion Technologies, Inc. (NYSE: ALUR) will be participating in the Jefferies London Healthcare Conference on November 14-16, 2023. The company's CEO and CFO will present on November 15 at 9:30 a.m. GMT and will be available for investor meetings. A live webcast of the event will be available on the Allurion website.

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced that it will be participating in the Jefferies London Healthcare Conference taking place on November 14-16, 2023 in London. Shantanu Gaur, Allurion’s Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will present on Wednesday, November 15, 2023 at 9:30 a.m. GMT, and will be available for investor 1x1 meetings.

A live webcast of the event will be available on the Allurion website, under Events & Presentations. You can also register for the live webcast here.

About Allurion

Allurion is dedicated to ending obesity. The Allurion Program is a weight-loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for healthcare providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor, and manage weight-loss therapy for patients regardless of their treatment plan, whether it is gastric balloon, surgical, medical or nutritional. The Allurion Gastric Balloon is an investigational device in the United States.

For more information about Allurion and the Allurion Virtual Care Suite, please visit www.allurion.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231106883069/en/

US Media

Brian Ruby

ICR

203-682-8268

brian.ruby@icrinc.com

Global Media

Cedric Damour

PR Manager

+33 7 84 21 02 20

cdamour@allurion.com

Investors

Mike Cavanaugh

ICR Westwicke

617-877-9641

mike.cavanaugh@westwicke.com

Source: Allurion Technologies, Inc.

FAQ

What is the name of the company participating in the conference?

The company participating in the conference is Allurion Technologies, Inc.

When and where is the Jefferies London Healthcare Conference taking place?

The Jefferies London Healthcare Conference is taking place on November 14-16, 2023 in London.

Who will be presenting at the conference?

Shantanu Gaur, Allurion's Chief Executive Officer, and Chris Geberth, Chief Financial Officer, will be presenting at the conference.

Will there be investor meetings available?

Yes, the company's CEO and CFO will be available for investor 1x1 meetings.

Will there be a webcast of the event?

Yes, a live webcast of the event will be available on the Allurion website.

How can I register for the live webcast?

You can register for the live webcast on the Allurion website.